Showing 841-850 of 9918 results for "".
FDA Approves Axillary Hyperhidrosis Treatment; Study Examines Biologic Outcomes in Psoriasis
https://practicaldermatology.com/series/dermwire-tv/fda-approves-axillary-hyperhidrosis-treatment-study-examines-biologic-outcomes-psoriasis/26562/In this week's DermwireTV, the FDA approves a first-of-its-kind gel for axillary hyperhidrosis; a new analysis examines how smoking, BMI, and age affect biologic outcomes in psoriasis; and the CEO of Aerolase joins us to discuss the latest trends in the aesthetic laser market.DermWireTV: Climate Change and Skin, Wynzora, Tremfya, Rinvoq Updates
https://practicaldermatology.com/topics/psoriasis/dermwiretv-climate-change-and-skin-wynzora-tremfya-rinvoq-updates/19834/The vast majority of dermatologists around the world—95.6 percent—believe climate change is occurring, and 88 percent think it will impact the incidence of skin diseases, according to the first international survey of dermatologists on the topic, conducted online by the International Society of DermSkin Cancer Prevention–Present and Future
https://practicaldermatology.com/programs/practical-dermatology/skin-cancer-prevention-present-and-future/18193/A panel discussion led by Neal Bhatia, MD, reveals the efforts – large and small – being made by dermatologists Laura Ferris, MD, Vishal Patel, MD, and Todd Schlesinger, MD, to combat skin cancer in their clinics and in their communities.The Use of Lasers and Energy-Based Devices in Patients with Richly Pigmented Skin
https://practicaldermatology.com/programs/practical-dermatology/the-use-of-lasers-and-energy-based-devices-in-patients-with-richly-pigmented-skin/18199/In the last of a three-part podcast series on dermatologic issues facing patients with darker skin tones, Andrew Alexis, MD, a dermatologist from New York City and the President of the Skin of Color Society, Corey Hartman, MD, a dermatologist in Birmingham, Alabama, and Janiene Luke, MD, a dermatolo50 Shades of Red
https://practicaldermatology.com/programs/practical-dermatology/50-shades-of-red/18192/Dr. Estee Williams, an assistant clinical professor of dermatology at Mount Sinai Medical Center in New York City and an official spokesperson for the National Rosacea Society, explains why treating rosacea is a marathon, not a sprint, in this episode of Practical Dermatology: The Podcast.Hair Loss in Patients With Diverse Skin Tones
https://practicaldermatology.com/programs/practical-dermatology/hair-loss-in-patients-with-skin-of-color/18194/In this first installment of a two-part episode of The Practical Dermatology Podcast, Brooke Jackson, MD, founder and owner of Skin Wellness Dermatology Associates in Durham, NC, and a dermatologic surgeon and dermatologist, speaks about hair loss in patients with diverse skin tones, the timing of hHair Loss in Patients With Diverse Skin Tones (Part 2)
https://practicaldermatology.com/programs/practical-dermatology/hair-loss-in-patients-with-diverse-skin-tones-part-2/18195/In this second installment of a two-part episode of The Practical Dermatology Podcast, Brooke Jackson, MD, founder and owner of Skin Wellness Dermatology Associates in Durham, NC, and a dermatologic surgeon and dermatologist, continues the conversation, focusing on different hair textures and stylesDermWireTV: Birch Triterpenes Gel Gets FDA Approval for EB, VTE Risk is Lower in Patients with AD, and Are Topical Steroids Affecting Bone Health?
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-birch-triterpenes-t-gel-gets-fda-approval-for-eb-vte-risk-is-lower-in-patients-with-ad-and-are-topical-steroids-affecting-bone-health/20233/A birch bark extract topical from Chiesi Global Rare Diseases represents the latest in treatment approvals for epidermolysis bullosa. Patients with atopic dermatitis may have a decreased risk for developing venous thromboembolism. Commonly prescribed topical steroids may raise some patients' risk foShifting Paradigms on Lentigo Maligna
https://practicaldermatology.com/conferences/maui-derm-2024/shifting-paradigms-on-lentigo-maligna/20255/According to Ashfaq Marghoob, MD, current research supports individualizing treatment of lentigo maligna (LM) based on what is the best therapeutic option, from active surveillance to surgery to radiation to imiquimod.Time Is Hair: An Update on the Diagnosis and Treatment of Scarring Alopecias in Patients with Darker Skin Tones
https://practicaldermatology.com/programs/practical-dermatology/time-is-hair-an-update-on-the-diagnosis-and-treatment-of-scarring-alopecia-in-patients-with-darker-skin-tones/18198/In part two of a three-part podcast series on dermatologic issues facing patients with darker skin tones, Dr. Andrew Alexis, a dermatologist from New York City and the President of the Skin of Color Society; Dr. Corey Hartman, a dermatologist in Birmingham, Alabama; and Dr. Janiene Luke, a dermatolo